Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Dietetic Association|September 1, 1993
Identifying predictive variables for long-term weight change after participation in a weight loss programM A Lavery, J W Loewy
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 1992
Statistical methods that distinguish between attributes of assessment: prolongation of life versus quality of lifeJ W Loewy, A S Kapadia, B Hsi, et al.
The American Journal of Sports Medicine|November 1, 1994
Upper extremity physical factors affecting tennis serve velocityD B Cohen, M A Mont, K R Campbell, et al.
The Journal of Arthroplasty|February 1, 1996
Cementless total knee arthroplasty in obese patients. A comparison with a matched control groupM A Mont, S K Mathur, K A Krackow, et al.
Journal of the American Dietetic Association|September 1, 1989
Long-term follow-up of weight status of subjects in a behavioral weight control programM A Lavery, J W Loewy, A S Kapadia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assayF A Holmes, H A Fritsche, J W Loewy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicinC Isaacs, N J Robert, F A Bailey, et al.
International Journal of Cancer|May 15, 1990
Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epitheliumS M Lippman, E J Peters, M J Wargovich, et al.
Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcomaM M Mita, E Poplin, C D Britten, et al.
Pageof 1